video

Dyadic (DYAI) Announces Effectiveness of Form 10 Registration Statement and Application to NASDAQ

JUPITER, FL / ACCESSWIRE / February 13, 2019 / Dyadic International, Inc. (the "Company") (OTCQX: DYAI) today announced that the Securities and Exchange...

‘Early Detection, Early Response.’ How Smallpox Which Killed 300 Million, Was Eradicated.

During the 20th century, it is estimated that smallpox was responsible for 300–500 million deaths. In the early 1950s, an estimated 50...

New Report: Citius (CTXR) Trades 13 Million Shares on CoronaVirus and Candida Auris News.

Announces Mino-lok® Erdicates the Deadly and Untreatable C. Auris Bacteria.Announces License of Treatment for CoronaVirus Respiratory Failure.
biotech stock review

Adding Mustang Bio (MBIO) $4.00 to Watchlist After Investor Presentation.

We met with management at Company-sponsored lunch at Ruth Chris in Boca Raton last week and we came away extremely enthusiastic about...

Adding Vaccinex (VCNX) $5.50, to Watch List After Investor Presentation.

IPO Tumbles in Aftermarket, from $12 underwritten by Oppenheimer, BTIG and Ladenburg Thalmann, to a low of $3 in six months.

Fortress Bio (FBIO) Inches Closer to $3.00 on Major News.

Fortress Bio (FBIO) Inches Closer to $3.00 on Major News. Citius Pharma (CTXR) Inches Closer to the Next Phase...
biotech stock review ATXI

Avenue Therapeutics (ATXI) Announces New Drug Application for IV Tramadol Accepted for Review by...

IV tramadol for the management of moderate to moderately severe pain in adults in a medically supervised health care setting.

VirnetX (VHC) Scores $440 Million and Citius Pharma (CTXR) Sees Market Expand to Over...

Internet Stock Review Blast from the past scores big! We added VirnetX (VHC)...
NanoVobronix, Biotech Stock Review

NanoVibronix (NAOV) $3.13 Announces CBD Patch and Cream for PainShield®

NanoVibronix Announces Planned Launch of CBD Patch and Cream for PainShield® Designed to Amplify Therapeutic Effect Combination of...

Latest article

Post Reverse Split, Tharimmune (THAR) Announces Positive Phase I Results.

This is a story of 're-purposed' FDA approved drug, from drug overdose, to a solution for unrelenting itching. If approved, it can...

Trump’s (DJT) up 48% Today

LIVE QUOTE Our only thought is it would be a great idea, to give...

Altamira Thera (CYTO) Explodes 144% Higher Post Reverse Split, With 50 Million Shares Trading...

Taking advantage of post reverse-split investor pessimism, is a VALID investing technique. Altamira is developing and supplying peptide-based...